FODAY KOROMA: Open Payments
NPI 1710687132 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,530 in 181 payments from 20 companies in 2025. Trend: 2023 $1,686 · 2024 $9,799 · 2025 $6,530
Food & beverage: $6,461Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $1,840 |
| Galderma Laboratories, L.P. | 14 | $686 |
| UCB, Inc. | 26 | $679 |
| LEO Pharma Inc. | 14 | $643 |
| GENZYME CORPORATION | 13 | $611 |
| Arcutis Biotherapeutics, Inc. | 13 | $444 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $376 |
| Lilly USA, LLC | 12 | $278 |
| Organon LLC | 4 | $225 |
| PFIZER INC. | 4 | $170 |
Products named: SKYRIZI, RINVOQ, DUPIXENT, NEMLUVIO, Bimzelx, Zoryve, ADBRY, SILIQ.
Industry payments across NY — which companies pay providers there.
